InsiderTradesSIGMA

InsidersTradesSigma

Unknown · Dirigeant — insider filings · 58 reports

← Executives ★ Sign in to follow

U

Unknown

Dirigeant

Other

DK·Finanstilsynet DK

H. Lundbeck A/S

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Explore the complete record of transactions filed by Unknown, Dirigeant. Director active across 1 companies, notably H. Lundbeck A/S. In total, 58 reports have been published. The latest transaction was disclosed on 18 February 2026 — Sale. Regulator: Finanstilsynet DK. The full history is free.

Declarations58 total

Executives●SaleHH. Lundbeck A/S8DK FSA

U

€3,893808 shares@ €4.81810.0000% mcap0.1% of flow

ShareNASDAQ Copenhagen XCSE

DK:1420949·18 Feb 2026

Executives●PurchaseHH. Lundbeck A/S8DK FSA

U

ShareNASDAQ Copenhagen XCSE and Cboe Europe Equities - European

DK:1418543·6 Feb 2026

Ideal exit: 3 Nov 2026 (T+270)

Executives●OtherHH. Lundbeck A/S8DK FSA

U

ShareNASDAQ Copenhagen XCSE

DK:1417843·4 Feb 2026

Executives●SaleHH. Lundbeck A/S8DK FSA

U

€48382 shares@ €5.89050.0000% mcap0.0% of flow

ShareNASDAQ Copenhagen XCSE

DK:1404921·8 Dec 2025

Executives●PurchaseHH. Lundbeck A/S8DK FSA

U

€100,68522,529 shares@ €4.46910.0003% mcap0.3% of flow

Share

DK:1275549·15 Feb 2024

Ideal exit: 11 Nov 2024 (T+270)

Executives●OtherHH. Lundbeck A/S8DK FSA

U

06,737 shares0

Share

DK:1273307·7 Feb 2024

Executives●PurchaseHH. Lundbeck A/S8DK FSA

U

€4,4521,000 shares@ €4.45250.0000% mcap0.1% of flow

Share

DK:1262896·1 Dec 2023

Ideal exit: 27 Aug 2024 (T+270)

Executives●PurchaseHH. Lundbeck A/S9DK FSA

U

€268,27754,138 shares@ €4.95540.0007% mcap8.4% of flow

Share

DK:1227808·12 May 2023

Ideal exit: 6 Feb 2024 (T+270)

Executives●PurchaseHH. Lundbeck A/S8DK FSA

U

€33,6728,399 shares@ €4.0090.0001% mcap1.1% of flow

Share

DK:1206307·10 Feb 2023

Ideal exit: 7 Nov 2023 (T+270)

Executives●PurchaseHH. Lundbeck A/S5DK FSA

U

€33,7591,679 shares@ €20.10680.0001% mcap0.1% of flow

Share

DK:1139553·11 Feb 2022

Ideal exit: 8 Nov 2022 (T+270)

Executives●PurchaseHH. Lundbeck A/S5DK FSA

U

€67,0683,385 shares@ €19.81330.0002% mcap0.2% of flow

Share

DK:1139190·10 Feb 2022

Ideal exit: 7 Nov 2022 (T+270)

Executives●OtherHH. Lundbeck A/S5DK FSA

U

037,092 shares0

Share

DK:1138764·9 Feb 2022

Executives●PurchaseHH. Lundbeck A/S8DK FSA

U

€65,6262,439 shares@ €26.90680.0002% mcap0.2% of flow

Share

DK:1033638·25 May 2021

Ideal exit: 19 Feb 2022 (T+270)

Executives●PurchaseHH. Lundbeck A/S8DK FSA

U

€133,7264,239 shares@ €31.54670.0003% mcap4.2% of flow

Share

DK:1008193·4 Mar 2021

Ideal exit: 29 Nov 2021 (T+270)

Executives●PurchaseHH. Lundbeck A/S8DK FSA

U

€66,5732,000 shares@ €33.28660.0002% mcap2.1% of flow

Share

DK:1003605·8 Feb 2021

Ideal exit: 5 Nov 2021 (T+270)

Executives●SaleHH. Lundbeck A/S8DK FSA

U

€134,1684,000 shares@ €33.54210.0003% mcap4.2% of flow

Share

DK:1003519·8 Feb 2021

Executives●OtherHH. Lundbeck A/S8DK FSA

U

04,030 shares0

Share

DK:1003122·4 Feb 2021

Executives●SaleHH. Lundbeck A/S9DK FSA

U

€162,4335,000 shares@ €32.48660.0004% mcap5.1% of flow

Share

DK:940043·13 May 2020

Executives●GrantHH. Lundbeck A/S8DK FSA

U

ShareIssued by Lundbeck LLC

DK:924852·2 Mar 2020

Executives●SaleHH. Lundbeck A/S8DK FSA

U

€1m29,500 shares@ €35.88250.0027% mcap3.1% of flow

Share

DK:891142·21 May 2019

Executives●SaleHH. Lundbeck A/S8DK FSA

U

€142,8234,000 shares@ €35.70580.0004% mcap0.4% of flow

Share

DK:890977·20 May 2019

Executives●PurchaseHH. Lundbeck A/S8DK FSA

U

€127,7823,500 shares@ €36.50930.0003% mcap0.4% of flow

Share

DK:889374·9 May 2019

Ideal exit: 3 Feb 2020 (T+270)

Executives●SaleHH. Lundbeck A/S10DK FSA

U

€4m80,000 shares@ €47.40440.0095% mcap11.1% of flow

ShareNASDAQ Copenhagen XCSE

DK:811725·21 Nov 2017

Executives●SaleHH. Lundbeck A/S8DK FSA

U

ShareNASDAQ Copenhagen XCSE

DK:789043·28 Aug 2017

Executives●OtherHH. Lundbeck A/S10DK FSA

U

€3m160,000 shares@ €20.99730.0084% mcap9.9% of flow

Share

DK:787682·18 Aug 2017

25 of 58 declarations

About Unknown

The individual associated with H. Lundbeck A/S holds an executive role within the company. Although their name is not specified, they are involved in the management and strategic decision-making for this well-established pharmaceutical company. Their role is crucial for the development and implementation of the company's strategies in the market.